Arrowstreet Capital’s Corcept Therapeutics CORT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$57.9M Sell
788,809
-703,418
-47% -$51.6M 0.04% 382
2025
Q1
$170M Sell
1,492,227
-152,715
-9% -$17.4M 0.14% 141
2024
Q4
$82.9M Buy
1,644,942
+64,321
+4% +$3.24M 0.07% 253
2024
Q3
$73.2M Buy
1,580,621
+97,199
+7% +$4.5M 0.06% 263
2024
Q2
$48.2M Sell
1,483,422
-203,249
-12% -$6.6M 0.04% 320
2024
Q1
$42.5M Buy
1,686,671
+585,568
+53% +$14.8M 0.04% 347
2023
Q4
$35.8M Sell
1,101,103
-4,366
-0.4% -$142K 0.04% 321
2023
Q3
$30.1M Buy
1,105,469
+822,279
+290% +$22.4M 0.04% 318
2023
Q2
$6.3M Buy
283,190
+273,097
+2,706% +$6.08M 0.01% 594
2023
Q1
$219K Sell
10,093
-12,955
-56% -$281K ﹤0.01% 1281
2022
Q4
$468K Buy
+23,048
New +$468K ﹤0.01% 1140
2022
Q2
Sell
-14,142
Closed -$318K 1257
2022
Q1
$318K Sell
14,142
-477,020
-97% -$10.7M ﹤0.01% 1069
2021
Q4
$9.73M Sell
491,162
-998,382
-67% -$19.8M 0.01% 660
2021
Q3
$29.3M Buy
1,489,544
+853,576
+134% +$16.8M 0.04% 432
2021
Q2
$14M Sell
635,968
-411,295
-39% -$9.05M 0.02% 732
2021
Q1
$24.9M Buy
1,047,263
+23,327
+2% +$555K 0.03% 508
2020
Q4
$26.8M Buy
1,023,936
+84,528
+9% +$2.21M 0.04% 495
2020
Q3
$16.4M Buy
939,408
+8,455
+0.9% +$147K 0.03% 630
2020
Q2
$15.7M Sell
930,953
-254,784
-21% -$4.29M 0.03% 602
2020
Q1
$14.1M Sell
1,185,737
-226,890
-16% -$2.7M 0.04% 388
2019
Q4
$17.1M Buy
+1,412,627
New +$17.1M 0.04% 429
2019
Q2
Sell
-314,400
Closed -$3.69M 1437
2019
Q1
$3.69M Buy
314,400
+91,650
+41% +$1.08M 0.01% 897
2018
Q4
$2.98M Buy
+222,750
New +$2.98M 0.01% 693
2018
Q3
Sell
-849,978
Closed -$13.4M 1110
2018
Q2
$13.4M Buy
849,978
+13,698
+2% +$215K 0.03% 369
2018
Q1
$13.8M Buy
836,280
+294,834
+54% +$4.85M 0.03% 381
2017
Q4
$9.78M Sell
541,446
-82,829
-13% -$1.5M 0.02% 446
2017
Q3
$12M Buy
624,275
+524,975
+529% +$10.1M 0.03% 347
2017
Q2
$1.17M Sell
99,300
-134,093
-57% -$1.58M ﹤0.01% 751
2017
Q1
$2.56M Buy
+233,393
New +$2.56M 0.01% 742